Abstract:E-cigarettes are thought to aid in tobacco smoking cessation, but there are concerns about their overall effectiveness and safety for the general population, particularly adults. This review aims to investigate the mechanisms of toxicity and adverse effects of e-cigarettes on the respiratory system, comparing these effects with those of conventional smoking. A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Searches were performed on PubMed, Embase, and the Cochrane Library using keywords, controlled vocabulary, and text words, with the following criteria: studies published in English from 2014 to 2024, open access, peer-reviewed, and full-text availability. Study selection, quality assessment, and data extraction were carried out by two independent reviewers. The Cochrane Risk of Bias 2.0 tool was used to evaluate the risk of bias in included randomized controlled trials, and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool was employed to assess the strength of evidence and determine its generalizability. Electronic nicotine delivery systems (ENDS) have diverse mechanisms of toxicity, including inflammation, hypoxia, cardiovascular stress, and metabolic changes. Reported adverse effects include cough, throat irritation, nausea, and hemodynamic changes. However, ENDS are associated with fewer risks compared to conventional cigarette smoking. ENDS users experience fewer respiratory and cardiovascular issues and have lower levels of biomarkers such as NNAL and CO compared to traditional smokers. Additionally, ENDS are more effective than nicotine replacement therapy (nicotine patches) for smoking cessation, particularly in pregnant women. The side effects of ENDS and nicotine-free vaping are similar to those of conventional smoking in pregnant women, with the exception of a lower birth weight among newborns exposed to ENDS (p < 0.05). ENDS present a complex balance of benefits and risks regarding respiratory health. While there are adverse effects, ENDS are considered less detrimental than conventional smoking and a viable option for smoking cessation. Longitudinal studies are needed to evaluate their safety with long-term use (>16 weeks). Policymakers and health practitioners should use these findings to develop balanced public health policies that weigh the benefits of ENDS against potential health risks, enabling informed decision-making for users.

Exploring the Utility of Long Non-Coding RNAs for Assessing the Health Consequences of Vaping

The Untapped Biomarker Potential of MicroRNAs for Health Risk-Benefit Analysis of Vaping vs. Smoking

Abstract 12461: Identification of Differentially Expressed Long Non-Coding RNAs in Human-Induced Pluripotent Stem Cell-Derived Endothelial Cells Triggered by E-cigarette Exposure

Immunological and toxicological risk assessment of e-cigarettes

Single cell RNA-sequencing of human precision-cut lung slices: A novel approach to study the effect of vaping and viral infection on lung health

An examination of the methods and variables used in experimental design that impact the toxicological outcomes of e-cigarettes

E-Cigarette Use: Device Market, Study Design, and Emerging Evidence of Biological Consequences

Epigenomic Dysregulation in Youth Vapers: Implications for Disease Risk Assessment

Health effects and known pathology associated with the use of E-cigarettes

Has the mist been peered through? Revisiting the building blocks of human health risk assessment for electronic cigarette use

Lipid laden macrophages and electronic cigarettes in healthy adults

Health outcomes of electronic cigarettes

A comprehensive toxicological analysis of panel of unregulated e-cigarettes to human health

Vaping and Respiratory Viruses: The End for ENDS?

Assessment of Respiratory Health Implications of Vaping: A Systematic Review of Toxicity Mechanisms and Adverse Effects of Electronic Nicotine Delivery Systems

A Systematic Literature Review on the Composition, Health Impacts, and Regulatory Dynamics of Vaping

Mechanisms of E-Cigarette Vape-Induced Epithelial Cell Damage

Chronic electronic cigarette use elicits molecular changes related to pulmonary pathogenesis

Predicting molecular mechanisms, pathways, and health outcomes induced by Juul e-cigarette aerosol chemicals using the Comparative Toxicogenomics Database

E-Cigarette Aerosol Condensate Leads to Impaired Coronary Endothelial Cell Health and Restricted Angiogenesis

Multidimensional assessment of the biological effects of electronic cigarettes on lung bronchial epithelial cells